• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动类型(阵发性与非阵发性)对长期临床结局的影响:RAFFINE注册研究亚分析

Impact of atrial fibrillation type (paroxysmal vs. non-paroxysmal) on long-term clinical outcomes: The RAFFINE registry subanalysis.

作者信息

Wada Hideki, Miyauchi Katsumi, Suwa Satoru, Miyazaki Sakiko, Hayashi Hidemori, Yamashiro Kazuo, Tanaka Ryota, Nishizaki Yuji, Nojiri Shuko, Sumiyoshi Masataka, Nakazato Yuji, Urabe Takao, Hattori Nobutaka, Minamino Tohru, Daida Hiroyuki

机构信息

Department of Cardiovascular Medicine, Juntendo University Shizuoka Hospital, Shizuoka, Japan.

Department of Cardiovascular Medicine, Juntendo Tokyo Koto Geriatric Medical Center, Tokyo, Japan.

出版信息

J Cardiol. 2023 May;81(5):450-455. doi: 10.1016/j.jjcc.2022.12.010. Epub 2023 Jan 12.

DOI:10.1016/j.jjcc.2022.12.010
PMID:36640907
Abstract

BACKGROUND

The type of atrial fibrillation (AF) (paroxysmal or non-paroxysmal) is important in determining its therapeutic management. However, the prognostic impact of AF type on the incidence of cardiovascular events remains uncertain.

METHODS

We investigated patients with AF who were selected from an observational, multicenter, prospective registry (RAFFINE) comprising 4 university hospitals and 50 general hospitals/clinics in Japan between 2013 and 2015. In this subanalysis study, patients were divided into two groups according to their AF pattern at the time of enrollment. The primary outcome was the composite of death, ischemic stroke, and heart-failure-related hospitalization.

RESULTS

Among 3845 patients, 1472 (38.3 %) and 2373 (61.7 %) had paroxysmal and non-paroxysmal type AF, respectively. Patients with non-paroxysmal AF were older and had higher CHADS score and prevalence of comorbidities. During median follow-up of 3.7 years, 681 (17.7 %) primary endpoints were identified. Cumulative incidences of the primary endpoint were significantly higher in the non-paroxysmal AF group; however, rates of bleeding events were not significantly different between the groups. Multivariate Cox hazard analysis showed that non-paroxysmal AF had significantly higher risk of cardiovascular events compared with paroxysmal AF (hazard ratio, 1.38; 95 % confidence interval, 1.17-1.64; p = 0.0002).

CONCLUSIONS

Non-paroxysmal AF was significantly associated with cardiovascular events. Long-term clinical outcomes might be improved if transition from paroxysmal to non-paroxysmal AF can be prevented.

摘要

背景

心房颤动(AF)的类型(阵发性或非阵发性)对于确定其治疗管理很重要。然而,AF类型对心血管事件发生率的预后影响仍不确定。

方法

我们调查了从2013年至2015年在日本的4所大学医院和50所综合医院/诊所组成的观察性、多中心、前瞻性登记处(RAFFINE)中选取的AF患者。在这项亚分析研究中,患者根据入组时的AF模式分为两组。主要结局是死亡、缺血性卒中和心力衰竭相关住院的复合终点。

结果

在3845例患者中,分别有1472例(38.3%)和2373例(61.7%)患有阵发性和非阵发性AF。非阵发性AF患者年龄更大,CHADS评分更高,合并症患病率更高。在3.7年的中位随访期间,确定了681例(17.7%)主要终点事件。非阵发性AF组主要终点的累积发生率显著更高;然而,两组之间的出血事件发生率没有显著差异。多变量Cox风险分析显示,与阵发性AF相比,非阵发性AF发生心血管事件的风险显著更高(风险比,1.38;95%置信区间,1.17 - 1.64;p = 0.0002)。

结论

非阵发性AF与心血管事件显著相关。如果能够预防从阵发性AF转变为非阵发性AF,可能会改善长期临床结局。

相似文献

1
Impact of atrial fibrillation type (paroxysmal vs. non-paroxysmal) on long-term clinical outcomes: The RAFFINE registry subanalysis.心房颤动类型(阵发性与非阵发性)对长期临床结局的影响:RAFFINE注册研究亚分析
J Cardiol. 2023 May;81(5):450-455. doi: 10.1016/j.jjcc.2022.12.010. Epub 2023 Jan 12.
2
Prognostic impact of heart rate during atrial fibrillation on clinical outcomes in elderly non-valvular atrial fibrillation patients: ANAFIE Registry sub-cohort study.老年非瓣膜性心房颤动患者心房颤动时心率对临床结局的预后影响:ANAFIE 登记研究亚组研究。
J Cardiol. 2023 May;81(5):441-449. doi: 10.1016/j.jjcc.2022.11.011. Epub 2022 Nov 22.
3
'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry.在欧洲,阵发性与非阵发性心房颤动患者的“真实世界”管理和结局:EURObservational Research Programme - Atrial Fibrillation(EORP-AF)一般试点登记研究。
Europace. 2016 May;18(5):648-57. doi: 10.1093/europace/euv390. Epub 2016 Jan 29.
4
Registry of Japanese patients with atrial fibrillation focused on anticoagulant therapy in the new era: The RAFFINE registry study design and baseline characteristics.聚焦新时代心房颤动日本患者抗凝治疗的登记研究:RAFFINE登记研究的设计与基线特征
J Cardiol. 2018 Jun;71(6):590-596. doi: 10.1016/j.jjcc.2017.10.021. Epub 2018 Mar 2.
5
The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events.心房颤动模式、抗凝治疗与心血管事件之间的关联。
Europace. 2020 Feb 1;22(2):195-204. doi: 10.1093/europace/euz292.
6
Clinical outcomes of ablation versus non-ablation therapy for atrial fibrillation in Japan: analysis of pooled data from the AF Frontier Ablation Registry and SAKURA AF Registry.日本房颤消融与非消融治疗的临床结局:来自 AF Frontier 消融登记研究和 SAKURA AF 登记研究的汇总数据分析。
Heart Vessels. 2021 Apr;36(4):549-560. doi: 10.1007/s00380-020-01721-x. Epub 2020 Nov 24.
7
The difference of burden of ectopic beats in different types of atrial fibrillation and the effect of atrial fibrillation type on stroke risk in a prospective cohort of patients with atrial fibrillation (CODE-AF registry).不同类型心房颤动患者异位搏动负担的差异及心房颤动类型对心房颤动患者前瞻性队列脑卒中风险的影响(CODE-AF 登记研究)。
Sci Rep. 2020 Apr 14;10(1):6319. doi: 10.1038/s41598-020-63370-4.
8
Thromboembolic risks associated with paroxysmal and persistent atrial fibrillation in Asian patients: a report from the Chinese atrial fibrillation registry.亚洲患者阵发性和持续性心房颤动相关的血栓栓塞风险:来自中国心房颤动注册研究的报告。
BMC Cardiovasc Disord. 2019 Nov 27;19(1):283. doi: 10.1186/s12872-019-1260-7.
9
Clinical Outcomes of Rhythm Control Strategies for Asymptomatic Atrial Fibrillation According to the Quality-of-Life Score: The CODE-AF (Comparison Study of Drugs for Symptom Control and Complication Prevention of Atrial Fibrillation) Registry.根据生活质量评分评估无症状性心房颤动的节律控制策略的临床结局:CODE-AF(心房颤动症状控制和并发症预防药物比较研究)注册研究。
J Am Heart Assoc. 2022 Sep 20;11(18):e025956. doi: 10.1161/JAHA.122.025956. Epub 2022 Sep 8.
10
Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry.醛固酮受体拮抗剂在心房颤动患者中的应用:来自 ORBIT-AF(房颤更明智治疗的结局登记研究)登记研究的结果。
J Am Heart Assoc. 2018 Apr 13;7(8):e007987. doi: 10.1161/JAHA.117.007987.

引用本文的文献

1
The impact of atrial fibrillation type on clinical outcomes and antithrombotic therapy at discharge in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a real-world study.急性冠状动脉综合征患者或接受经皮冠状动脉介入治疗患者的房颤类型对临床结局及出院时抗栓治疗的影响:一项真实世界研究
BMC Cardiovasc Disord. 2025 Aug 2;25(1):570. doi: 10.1186/s12872-025-05042-7.
2
Associations of Dietary and Lifestyle Components with Atrial Fibrillation.膳食和生活方式因素与心房颤动的关联。
Nutrients. 2024 Feb 5;16(3):456. doi: 10.3390/nu16030456.